articles details

Research
June 16, 2025

Aleeto® Nasal Spray (HAPPLEY®)

1)Dosage Form Characteristics:
The nasal spray leverages absorption across the nasal mucosa to bypass the blood–brain barrier, achieving high bioavailability and rapid central nervous system penetration. It is well suited for long-term management in mild to moderate cases.
2)Indications:
• Autism spectrum disorder (ASD)
• Amyotrophic lateral sclerosis (ALS)
• Post-stroke rehabilitation
• Alzheimer’s disease (AD) and other neurodegenerative disorders
3)Key Advantages:
• Convenience: Needle-free, self-administrable by patients.
• Central Targeting: Intranasal route enhances and accelerates CNS delivery.
• Chronic Disease Management: Supports maintenance therapy to improve patient quality of life.
• Reduced Systemic Burden: Localized nasal delivery minimizes hepatic and renal exposure.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Popular Post

Aleeto® Nasal Spray (HAPPLEY®)
Aleeto® Lyophilized Powder for Injection (ALEETO®)
Aleeto® Microneedle Patch (ECIWEP®)

Categories

  • Research Insights (02)
  • Laboratory Best Practices (04)
  • Innovation & Technology (01)
  • Industry Trends (03)
  • Sustainability in Science (05)
  • Events & Workshops (02)
  • Educational Resources (04)